M.A. Karsdal

37.0k total citations · 4 hit papers
860 papers, 25.4k citations indexed

About

M.A. Karsdal is a scholar working on Rheumatology, Molecular Biology and Oncology. According to data from OpenAlex, M.A. Karsdal has authored 860 papers receiving a total of 25.4k indexed citations (citations by other indexed papers that have themselves been cited), including 279 papers in Rheumatology, 205 papers in Molecular Biology and 159 papers in Oncology. Recurrent topics in M.A. Karsdal's work include Osteoarthritis Treatment and Mechanisms (196 papers), Protease and Inhibitor Mechanisms (103 papers) and Liver Disease Diagnosis and Treatment (98 papers). M.A. Karsdal is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (196 papers), Protease and Inhibitor Mechanisms (103 papers) and Liver Disease Diagnosis and Treatment (98 papers). M.A. Karsdal collaborates with scholars based in Denmark, United States and Germany. M.A. Karsdal's co-authors include Kim Henriksen, Anne‐Christine Bay‐Jensen, Claus Christiansen, Diana Julie Leeming, I. Byrjalsen, Per Qvist, Federica Genovese, Nicholas Willumsen, Mette Juul Nielsen and Virginia B. Kraus and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

M.A. Karsdal

809 papers receiving 25.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use

2015 447 citations Virginia B. Kraus, M.A. Karsdal et al. Osteoarthritis and Cartilage profile →
The good and the bad collagens of fibrosis – Their role in signaling and organ function

2017 363 citations M.A. Karsdal, Signe Holm Nielsen et al. profile →
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology

2019 342 citations M.A. Karsdal, Nicholas Willumsen et al. profile →
Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future

2016 274 citations M.A. Karsdal, C. Ladel et al. Osteoarthritis and Cartilage profile →

Peers

Countries citing papers authored by M.A. Karsdal

Since Specialization

Citations

This map shows the geographic impact of M.A. Karsdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Karsdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Karsdal more than expected).

Fields of papers citing papers by M.A. Karsdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Karsdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Karsdal. The network helps show where M.A. Karsdal may publish in the future.

Co-authorship network of co-authors of M.A. Karsdal

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Karsdal. A scholar is included among the top collaborators of M.A. Karsdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Karsdal. M.A. Karsdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The inflammatory endotype in osteoarthritis: Reflections from the 2024 OARSI clinical trials symposium (CTS) with a special emphasis on feasibility for clinical development 2025 ·Osteoarthritis and Cartilage Open ·M.A. Karsdal, Lucio C. Rovati, J. Tambiah, Olga Kubassova, C. Ladel, Francis Bérenbaum, Anne‐Christine Bay‐Jensen, (unknown), Richard F. Loeser, Ali Mobasheri, Virginia B. Kraus	1
2	The Calprotectin Fragment, CPa9-HNE, Is a Plasma Biomarker of Mild Chronic Obstructive Pulmonary Disease 2025 ·Cells ·(unknown), Jannie Marie Bülow Sand, Theo Borghuis, Diana Julie Leeming, M.A. Karsdal, Frank Klont, Russell P. Bowler, Barbro N. Melgert, Janette K. Burgess, Simon D. Pouwels	0
3	Dysregulation of circulating collagen turnover markers in very early systemic sclerosis 2024 ·RMD Open ·Rucsandra Dobrotă, Suzana Jordan, (unknown), Nicoletta Del Papa, Britta Maurer, Mike Oliver Becker, Carina Mihai, Anne‐Christine Bay‐Jensen, M.A. Karsdal, Anne Sofie Siebuhr, Oliver Distler	4
4	Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight 2024 ·British Journal of Pharmacology ·(unknown), (unknown), M.A. Karsdal, Kim Henriksen	3
5	Diagnostic potential of blood-based biomarkers in multiple sclerosis 2024 ·Frontiers in Neurology ·Signe Holm Nielsen, M.A. Karsdal, (unknown), Anne‐Christine Bay‐Jensen, (unknown)	1
6	Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD 2024 ·Journal of Internal Medicine ·(unknown), (unknown), Patrik Nasr, (unknown), Stergios Kechagias, Nils Nyhlin, Hanns–Ulrich Marschall, (unknown), (unknown), M.A. Karsdal, Diana Julie Leeming, Mattias Ekstedt, Hannes Hagström	3
7	Lot-to-Lot Variance in Immunoassays—Causes, Consequences, and Solutions 2023 ·Diagnostics ·Yunyun Luo, (unknown), Lasse Langholm, M.A. Karsdal, Anne‐Christine Bay‐Jensen, Shu Sun	20
8	POS0227 SERUM EXTRACELLULAR MATRIX BIOMARKERS IDENTIFY RESPONSE TO GUSELKUMAB IN PSORIATIC ARTHRITIS: POST-HOC ANALYSIS FROM A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY THROUGH 2 YEARS 2023 ·Annals of the Rheumatic Diseases ·Signe Holm Nielsen, Anne‐Christine Bay‐Jensen, Peder Frederiksen, M.A. Karsdal, M. Shawi, (unknown), Alexa P. Kollmeier, (unknown), Sheng Gao	0
9	Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism? 2023 ·Cardiovascular Diabetology ·Christian Stevns Hansen, Daniel Guldager Kring Rasmussen, Tine W. Hansen, Signe Holm Nielsen, Simone Theilade, M.A. Karsdal, Federica Genovese, Peter Rossing	3
10	Reflections from the 2021 OARSI clinical trial symposium: Considerations for understanding biomarker assessments in osteoarthritis drug development - Should future studies focus on disease activity, rather than status? 2022 ·SHILAP Revista de lepidopterología ·M.A. Karsdal, J. Tambiah, Marc C. Hochberg, C. Ladel, Anne‐Christine Bay‐Jensen, Lars Arendt‐Nielsen, Ali Mobasheri, Virginia B. Kraus	8
11	Collagen remodelling and plasma ascorbic acid levels in patients suspected of inherited bleeding disorders harbouring germline variants in collagen‐related genes 2020 ·Haemophilia ·(unknown), Eva Zetterberg, Maria Rossing, Tina Manon‐Jensen, (unknown), M.A. Karsdal, Jens Lykkesfeldt, Eva Leinøe	3
12	Assessment of liver fibrosis progression and regression by a serological collagen turnover profile 2018 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·M.A. Karsdal, Sara Toftegaard Hjuler, Yi Luo, Daniel Guldager Kring Rasmussen, Mette Juul Nielsen, Signe Holm Nielsen, Diana Julie Leeming, Zachary Goodman, Robert H. Arch, Keyur Patel, Detlef Schuppan	42
13	Development of a Neo-Epitope Specific Assay for Serological Assessment of Type VII Collagen Turnover and Its Relevance in Fibroproliferative Disorders 2018 ·Assay and Drug Development Technologies ·Jannie Marie Bülow Sand, (unknown), (unknown), Anne Sofie Siebuhr, L Iversen, Arkadiusz Nawrocki, Martin R. Larsen, Robyn T. Domsic, Nathalie Franchimont, Juan C. Chávez, M.A. Karsdal, Diana Julie Leeming	8
14	Remodeling of the Tumor Microenvironment Predicts Increased Risk of Cancer in Postmenopausal Women: The Prospective Epidemiologic Risk Factor (PERF I) Study 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Cecilie L. Bager, Nicholas Willumsen, S.N. Kehlet, Henrik B. Hansen, Anne‐Christine Bay‐Jensen, Diana Julie Leeming, (unknown), Jesper Skov Neergaard, Claus Christiansen, Estrid Høgdall, M.A. Karsdal	12
15	Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients 2013 ·European Respiratory Journal ·Jannie Marie Bülow Sand, Federica Genovese, Fernando J. Martínez, MeiLan K. Han, Cory M. Hogaboam, M.A. Karsdal, Diana Julie Leeming	1
16	Tumor Necrosis Factor-Alpha and Receptor Activator of Nuclear Factor-κB Ligand Augment Human Macrophage Foam-Cell Destruction of Extracellular Matrix Through Protease-Mediated Processes 2011 ·Assay and Drug Development Technologies ·Helene Skjøt‐Arkil, Natasha Barascuk, Lise Larsen, Morten Hanefeld Dziegiel, Kim Henriksen, M.A. Karsdal	5
17	Macrophage-Mediated Proteolytic Remodeling of the Extracellular Matrix in Atherosclerosis Results in Neoepitopes: A Potential New Class of Biochemical Markers 2010 ·Assay and Drug Development Technologies ·Helene Skjøt‐Arkil, Natasha Barascuk, Thomas C. Register, M.A. Karsdal	30
18	Mechanisms of the Anabolic Effects of Teriparatide on Bone: Insight From the Treatment of a Patient With Pycnodysostosis 2008 ·Journal of Bone and Mineral Research ·Pascale Chavassieux, M.A. Karsdal, Toni Segovia‐Silvestre, A.V. Neutzsky-Wulff, Roland Chapurlat, Georges Boivin, Pierre D. Delmas	47
19	In Vitro, Ex Vivo , and In Vivo Methodological Approaches for Studying Therapeutic Targets of Osteoporosis and Degenerative Joint Diseases: How Biomarkers Can Assist? 2005 ·Assay and Drug Development Technologies ·Sophie Schaller, Kim Henriksen, Pernille Høegh-Andersen, B.C. Søndergaard, E.U. Sumer, László B. Tankó, Per Qvist, M.A. Karsdal	93
20	A2 GADD45β is novel mediator of MMP-13 gene expression during chondrocyte hypertrophy 2005 ·Osteoarthritis and Cartilage ·B.C. Søndergaard, Kim Henriksen, (unknown), Søren Østergaard, Per Qvist, Yu Z. Bagger, Claus Christiansen, (unknown), M.A. Karsdal, Kosei Ijiri, Luiz F. Zerbini, Haibing Peng, Nicole C. Walsh, Xiaogang Huang, Hasan H. Otu, Binfeng Lu, Towia A. Libermann, Mary B. Goldring	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact